Bioequivalence of 250 mg lysine clonixinate tablets after a single oral dose in a healthy female Mexican population under fasting conditions

Citations Over TimeTop 23% of 2010 papers

Abstract

This single-dose study found that both 250-mg immediate-release tablets of lysine clonixinate met the Mexican regulatory criteria for bioequivalence in these volunteers.

Related Papers

• → Absorption Rate Vs. Exposure: Which Is More Useful for Bioequivalence Testing?(1996)60 cited
• Choice of characteristics and their bioequivalence ranges for the comparison of absorption rates of immediate-release drug formulations.(1994)
• → Assessment of Key Pharmacokinetic Variables of Bioequivalent and Non-bioequivalent Enrofloxacin Preparations under Various Water Management Conditions(2010)5 cited
• Pharmacokinetic Evaluation of a Gastrointestinal Motility Tretment of Drug in Healthy Human Volunteers (Cinitapride)(2009)